Average Co-Inventor Count = 2.36
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dicerna Pharmaceuticals, Inc. (55 from 99 patents)
2. Curis, Inc. (5 from 141 patents)
3. Novo Nordisk A/s (3 from 1,777 patents)
60 patents:
1. 12435336 - Compositions and methods for inhibiting LPA expression
2. 12252691 - Compositions and methods for inhibiting LPA expression
3. 12234456 - Compositions and methods for modulating APOC3 expression
4. 12084662 - Compositions and methods for modulating PNPLA3 expression
5. 11952574 - Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression
6. 11912996 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
7. 11873493 - Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
8. 11851658 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
9. 11773390 - Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA
10. 11697812 - Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
11. 11667918 - Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
12. 11661604 - Methods and compositions for inhibiting expression of LDHA
13. 11655473 - Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (MARC1) expression
14. 11578329 - Compositions and methods for inhibiting nuclear receptor subfamily 1 group H member 3 (NR1H3) expression
15. 11572562 - Compositions and methods for inhibiting GYS2 expression